KIDRON MIRIAM (Chief Scientific Officer) exercised options at ORAMED PHARMACEUTICALS INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 1/29/2026ACC: 0001213900-26-009478
DirectorOfficer· Chief Scientific Officer
Since Feb 2019
0.00
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
19K acquired · 19K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+19K
Price / share
—
Trade value
—
% of position
1.3%
1/22/2026
1.43M→1.45M
Total
Net shares
+19K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/22/2026 | M · Option Exercise | +19K | — | — | 1.3% | 1.43M | 1.45M |
| Total | +19K | $0.00 | ||||||
Derivative Transactions1
Performance Stock Units
Direct
Converts to
Common Stock
19K shares
Shares
−19K
Strike price
Held after
0.00
Exercisable
—
1/22/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Performance Stock Units Direct | Common Stock19K shares | 1/22/2026 | M · Option Exercise | −19K | — | 0.00 |